Page 128 - Eshre Final Programme 2015
P. 128
10:00 - 11:45 Lisbon
Selected oral communications: Session 58: Assessing blastocyst development and stem cell potency
Chairman: B. Heindryckx (Belgium) Chairman: R. Ramalho (Portugal)
10:00 O-210
10:15 O-211
10:30 O-212
10:45 O-213
Predicting pregnancy outcomes using a non-invasive analysis of secretome parameters in spent blastocyst culture media using MALDI-ToF MS in ART
F. Sharara1, R.K. Iles2, S.A. Butler2
1Virginia Center for Reproductive Medicine, RE/I, Reston, U.S.A. 2MAP Diagnostics, Research, London, United Kingdom
Blastocoel cavity contains miRNAs: novel potential biomarker of blastocyst quality
D. Cimadomo1, L. Noli2, A. Checchele3, E. Scepi1, R. Maggiulli1, C. Scarica1, D. Ilic2, F.M. Ubaldi1, L. Rienzi1, A. Capalbo1
1Clinica Valle Giulia, G.EN.E.R.A. Centre for Reproductive Medicine, Roma, Italy 2King's College, Assisted Conception Unit, London, United Kingdom
3Genetyx, Genetic diagnosis laboratory, Marostica, Italy
Association between blastocoel proteins abundance and embryo chromosomal status in humans
M. Poli1, A. Ori2, T. Child1, S. Jaroudi3, K. Spath1, M. Beck2, D. Wells1
1University of Oxford, Nuffield Dept of Obstetrics and Gynaecology, Oxford, United Kingdom
2European Molecular Biology Laboratory, Structural and Computational Biology Unit, Heidelberg, Germany
3Reprogenetics UK, Institute of Reproductive Sciences, Oxford, United Kingdom
Balancing between totipotency and differentiation in the human embryo
M. Krivega1, M. Geens1, H. Tournaye2, H. Van de Velde2
1Vrije Universiteit Brussel, Reproduction and Genetics, Brussels, Belgium 2UZ Brussel, Centre for Reproductive Medicine, Brussels, Belgium

   126   127   128   129   130